FDA Licenses First Freeze-dried Emergency Plasma
The room-temperature-stable freeze-dried plasma product provides a new option for patients in remote or austere environments where conventional frozen plasma is unavailable.
The room-temperature-stable freeze-dried plasma product provides a new option for patients in remote or austere environments where conventional frozen plasma is unavailable.
Baxter has recommended removal of certain Duo-Vent solution sets used for administration of fluids to the patient's vascular system.
HHS secretary Robert F Kennedy, Jr signed determinations to end COVID-19 emergency use authorizations for drugs, biological products, and medical devices because the emergency circumstances no longer exist.
On July 1, international organizations aim to increase awareness and research for bronchiectasis to improve patient outcomes and healthcare access.
The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.
The FDA authorized 20 Zyn nicotine pouches, including 10 flavored products, despite concerns from health experts over increased youth use.
Baxter issued an Urgent Medical Device Correction notice for all Volara System patient circuits to be corrected prior to continued use, according to an FDA alert.